TY - GEN AU - Chiarion Sileni,Vanna AU - MandalĂ ,Mario AU - Queirolo,Paola TI - [Pembrolizumab for the treatment of melanoma: updates and perspectives.] SN - 2038-1840 PY - 2018///0927 KW - Antibodies, Monoclonal, Humanized KW - administration & dosage KW - Antineoplastic Agents, Immunological KW - Humans KW - Immunotherapy KW - methods KW - Melanoma KW - drug therapy KW - Programmed Cell Death 1 Receptor KW - antagonists & inhibitors KW - Survival Rate N1 - Publication Type: Journal Article; Review UR - https://doi.org/10.1701/2829.28585 ER -